Application of SILCS to potassium channel hERG1 read more here.


SilcsBio Co-Founder Alex MacKerell, PhD Receives ACS Award for Computers in Chemical and Pharmaceutical Research

Dr. MacKerell to be honored at the ACS Spring 2022 National Meeting, March 20-24, in San Diego March 10, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, announced today its Co-Founder and Chief Scientific Officer, Alexander D. MacKerell Jr., [...]

March 10th, 2022|

Technical Sales for Drug Design Portfolio

Immediate Job Opening – 1/20/2022 Technical Sales Within Early Charm’s Drug Design Portfolio   SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other companies in its Drug Design Portfolio.   What we do: Early Charm creates, owns, and operates businesses that convert science into [...]

January 20th, 2022|
Go to Top